Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-22-0251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Teresa Ramone und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Medullary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Somatic copy number alterations (SCNA) involving either a whole chromosome or just one of the arms, or even smaller parts, have been described in about 88% of human tumors. This study investigated the SCNA profile in 40 well-characterized sporadic medullary thyroid carcinomas by comparative genomic hybridization array. We found that 26/40 (65%) cases had at least one SCNA. The prevalence of SCNA, and in particular of chromosome 3 and 10, was significantly higher in cases with a RET somatic mutation. Similarly, SCNA of chromosomes 3, 9, 10 and 16 were more frequent in cases with a worse outcome and an advanced disease. By the pathway enrichment analysis, we found a mutually exclusive distribution of biological pathways in metastatic, biochemically persistent and cured patients. In particular, we found gain of regions involved in the intracellular signaling and loss of regions involved in DNA repair and TP53 pathways in the group of metastatic patients. Gain of regions involved in the cell cycle and senescence were observed in patients with biochemical disease. Finally, gain of regions associated with the immune system and loss of regions involved in the apoptosis pathway were observed in cured patients suggesting a role of specific SCNA and corresponding altered pathways in the outcome of sporadic MTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy.
- Department of Laboratory Medicine, Section of Cytogenetics, University Hospital of Pisa, Pisa, Italy.
- Laboratorio di Biologia Bio@SNS, Scuola Normale Superiore, Pisa, Italy.
- Department of Information Engineering, University of Pisa, Pisa, Italy.
- Department of Surgical, Medical, Molecular Pathology and Critical Area, Unit of Pathology, University Hospital of Pisa, Pisa, Italy.
ORCID-Profile: Cristina Romei, Antonio Matrone, Paolo Piaggi, Rossella Elisei
Zitieren
APA
Ramone, T., Romei, C., Ciampi, R., Casalini, R., Valetto, A., Bertini, V., Raimondi, F., Onoja, A., Prete, A., Matrone, A., Gambale, C., Piaggi, P., Torregrossa, L., Ugolini, C., & Elisei, R. (2023). Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome. Endocrine-Related Cancer. https://doi.org/10.1530/erc-22-0251
Vancouver
Ramone T, Romei C, Ciampi R, Casalini R, Valetto A, Bertini V, et al. Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome. Endocrine-Related Cancer. 2023. doi:10.1530/erc-22-0251
BibTeX
@article{Ramone2023,
author = {Ramone, Teresa and Romei, Cristina and Ciampi, Raffaele and Casalini, Roberta and Valetto, Angelo and Bertini, Veronica and Raimondi, Francesco and Onoja, Anthony and Prete, Alessandro and Matrone, Antonio and Gambale, Carla and Piaggi, Paolo and Torregrossa, Liborio and Ugolini, Clara and Elisei, Rossella},
title = {Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-22-0251}
}
EUVIMED